Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell function in sentinel nodes.

Richard Essner1, Masayuki Kojima

  • 1Division of Surgical Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California 90404, USA.

Oncology (Williston Park, N.Y.)
|February 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers in Melanoma: Updates in Prognosis and Management.

Cancers·2026
Same author

Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort Analysis.

Dermatology and therapy·2026
Same author

Single-Arm Robotic Pancreaticoduodenectomy Using the da Vinci SP Surgical System With a Right Posterior Approach and External Traction.

Journal of hepato-biliary-pancreatic sciences·2026
Same author

Variation in the Surgical Care of Early Stage Melanoma Based on Surgical Subspecialty: Evaluation of Large Healthcare System.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2026
Same author

C4orf3 Regulates HIF-1α Degradation Under Hypoxic Conditions and Contributes to the Malignant Phenotype in Small Cell Lung Cancer.

Journal of Cancer·2026
Same author

Robotic crush and clip technique for pancreatic transection in robotic distal pancreatectomy.

Surgical endoscopy·2025
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Sentinel lymph node biopsy in early melanoma shows reduced expression of immune markers like CD80 and CD86. This finding may be key to understanding tumor-lymph node interactions.

Area of Science:

  • Oncology
  • Immunology
  • Surgical Pathology

Background:

  • Intraoperative lymphatic mapping and sentinel lymphadenectomy is a key technique for staging early-stage melanoma.
  • This method allows for detailed analysis of the sentinel lymph node's interaction with the primary tumor.

Purpose of the Study:

  • To investigate the expression of dendritic cell activation markers and T-cell receptors in sentinel versus nonsentinel lymph nodes from early-stage melanoma patients.
  • To assess the potential role of these markers in the immunologic interaction between the primary tumor and the regional lymph node basin.

Main Methods:

  • Lymphatic mapping and sentinel lymphadenectomy were performed on 25 patients with early-stage melanoma.
  • Sentinel and nonsentinel nodes were analyzed for routine pathology and expression of dendritic cell markers (CD80, CD86, CD40) and T-cell receptors (CTLA-4, CD28) using reverse transcription polymerase chain reaction.

Related Experiment Videos

Main Results:

  • A significant reduction in the expression of CD80 (77%), CD86 (77%), CD40 (85%), CTLA-4 (88%), and CD28 (85%) was observed in sentinel nodes compared to nonsentinel nodes.
  • This diminished expression was independent of B-cell (CD20) and T-cell (CD2) expression.

Conclusions:

  • Sentinel lymphadenectomy provides detailed pathologic and molecular characterization of sentinel nodes.
  • The quantitative reduction in dendritic cell markers in sentinel nodes suggests a role in the primary tumor-lymph node immunologic interaction and may aid in sentinel node identification.